FDA completes inspection on Abbott site
This article was originally published in Clinica
Executive Summary
The saga of Abbott's consent decree, which was imposed on the company by the FDA after the company repeatedly failed to comply with the FDA's good manufacturing practice and quality system regulation over a six-year period, may be drawing to a close.